News Merck to buy animal health firm Antelliq for $2.4bn Merck & Co is to buy animal health firm Antelliq Group for $2.4 billion in a bid to bolster this fast-growing business unit.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
